Published in PLoS Comput Biol on June 24, 2010
Effective--a database of predicted secreted bacterial proteins. Nucleic Acids Res (2010) 1.23
FindFoci: a focus detection algorithm with automated parameter training that closely matches human assignments, reduces human inconsistencies and increases speed of analysis. PLoS One (2014) 0.92
Identification of Secretory Proteins in Mycobacterium tuberculosis Using Pseudo Amino Acid Composition. Biomed Res Int (2016) 0.81
NClassG+: A classifier for non-classically secreted Gram-positive bacterial proteins. BMC Bioinformatics (2011) 0.81
Identification and Characterization of Lipase Activity and Immunogenicity of LipL from Mycobacterium tuberculosis. PLoS One (2015) 0.76
Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro. Chem Biol Drug Des (2014) 0.76
Heterogeneity among Homologs of Cutinase-Like Protein Cut5 in Mycobacteria. PLoS One (2015) 0.75
Secretome Prediction of Two M. tuberculosis Clinical Isolates Reveals Their High Antigenic Density and Potential Drug Targets. Front Microbiol (2017) 0.75
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
Improved prediction of signal peptides: SignalP 3.0. J Mol Biol (2004) 48.40
Global analysis of protein localization in budding yeast. Nature (2003) 33.22
Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc (2007) 19.50
A combined transmembrane topology and signal peptide prediction method. J Mol Biol (2004) 15.77
A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol (1998) 14.18
General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A (1985) 8.77
PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics (2004) 7.15
Common principles of protein translocation across membranes. Science (1996) 7.00
Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci (2003) 6.85
Swiss-Prot: juggling between evolution and stability. Brief Bioinform (2004) 5.73
The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol (1998) 5.08
Moonlighting proteins. Trends Biochem Sci (1999) 4.53
Improved method for predicting linear B-cell epitopes. Immunome Res (2006) 4.32
Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev (2003) 4.14
Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol Mol Biol Rev (2000) 3.81
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis. Trends Microbiol (2001) 3.58
Non-classical protein secretion in bacteria. BMC Microbiol (2005) 3.17
Prediction of twin-arginine signal peptides. BMC Bioinformatics (2005) 3.03
Moonlighting proteins: old proteins learning new tricks. Trends Genet (2003) 2.97
Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett (1994) 2.73
SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol Microbiol (2003) 2.62
Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics (2007) 2.24
Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis. J Bacteriol (1990) 2.10
Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc Natl Acad Sci U S A (2003) 2.00
Protein secretion systems in Mycobacteria. Cell Microbiol (2007) 1.94
A protein secretion pathway critical for Mycobacterium tuberculosis virulence is conserved and functional in Mycobacterium smegmatis. J Bacteriol (2005) 1.81
Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol Cell Proteomics (2003) 1.77
Methods for predicting bacterial protein subcellular localization. Nat Rev Microbiol (2006) 1.77
Three pathways for trehalose biosynthesis in mycobacteria. Microbiology (2000) 1.73
Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol Biol Cell (2004) 1.73
Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol (2004) 1.67
LocateP: genome-scale subcellular-location predictor for bacterial proteins. BMC Bioinformatics (2008) 1.64
Identification of outer membrane proteins of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2008) 1.63
Proteome analysis of Bacillus subtilis extracellular proteins: a two-dimensional protein electrophoretic study. Microbiology (2000) 1.52
Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components. FEMS Microbiol Rev (2004) 1.51
A machine-learning approach for predicting B-cell epitopes. Mol Immunol (2008) 1.40
Regulation of the Mycobacterium tuberculosis mce1 operon. J Bacteriol (2006) 1.37
Breaking down the wall: fractionation of mycobacteria. J Microbiol Methods (2006) 1.35
ANTHEPROT: an integrated protein sequence analysis software with client/server capabilities. Comput Biol Med (2001) 1.32
The TB structural genomics consortium: providing a structural foundation for drug discovery. Curr Drug Targets Infect Disord (2002) 1.28
Lipoprotein synthesis in mycobacteria. Microbiology (2007) 1.22
Gpos-PLoc: an ensemble classifier for predicting subcellular localization of Gram-positive bacterial proteins. Protein Eng Des Sel (2007) 1.18
Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. APMIS (2009) 1.17
Pathfinders and trailblazers: a prokaryotic targeting system for transport of folded proteins. FEMS Microbiol Lett (2006) 1.16
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology (2005) 1.13
Prediction of antigenic epitopes on protein surfaces by consensus scoring. BMC Bioinformatics (2009) 1.12
Identification of Mycobacterium tuberculosis H37Rv integral membrane proteins by one-dimensional gel electrophoresis and liquid chromatography electrospray ionization tandem mass spectrometry. J Proteome Res (2005) 1.11
Amino acids at positions 3 and 4 determine the membrane specificity of Pseudomonas aeruginosa lipoproteins. J Biol Chem (2007) 1.06
Expression and characterization of alpha-(1,4)-glucan branching enzyme Rv1326c of Mycobacterium tuberculosis H37Rv. Protein Expr Purif (2006) 1.05
Proteome analysis of the plasma membrane of Mycobacterium tuberculosis. Comp Funct Genomics (2002) 0.98
Redox biology of Mycobacterium tuberculosis H37Rv: protein-protein interaction between GlgB and WhiB1 involves exchange of thiol-disulfide. BMC Biochem (2009) 0.97
Isolation of mak1 from Actinoplanes missouriensis and evidence that Pep2 from Streptomyces coelicolor is a maltokinase. J Basic Microbiol (2004) 0.94
The gene expression data of Mycobacterium tuberculosis based on Affymetrix gene chips provide insight into regulatory and hypothetical genes. BMC Microbiol (2007) 0.91
Proteomic analysis of low-abundant integral plasma membrane proteins based on gels. Cell Mol Life Sci (2006) 0.89
An intramolecular disulphide bond reduces the efficacy of a lipoprotein plasma membrane sorting signal. Mol Microbiol (2003) 0.89
Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics (2009) 0.84
Bacterial lipid modification of proteins for novel protein engineering applications. Protein Eng Des Sel (2004) 0.84
Antigenic properties and immunoelectron microscopic localization of Mycobacterium fortuitum beta-lactamase. Antimicrob Agents Chemother (1995) 0.82
Biotechnological aspects of membrane function. Crit Rev Biotechnol (1997) 0.80
Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells. J Mol Med (Berl) (2004) 1.46
Mechanisms of genetically-based resistance to malaria. Gene (2010) 1.37
Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21. Vaccine (2002) 1.16
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. Eur J Immunol (2003) 1.14
Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells. J Hepatol (2002) 0.95
Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation. Biochem Biophys Res Commun (2004) 0.94
Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes. Vaccine (2002) 0.94
Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Acc Chem Res (2008) 0.93
Molecular modeling and in silico characterization of Mycobacterium tuberculosis TlyA: possible misannotation of this tubercle bacilli-hemolysin. BMC Struct Biol (2011) 0.92
Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules. J Biol Chem (2010) 0.92
Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion. Protein Sci (2005) 0.92
Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine (2009) 0.91
Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Ann Epidemiol (2011) 0.90
Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration. Pharm Res (2004) 0.89
Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis. Exp Parasitol (2009) 0.89
Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein. J Biol Chem (2006) 0.88
Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides. Protein Sci (2005) 0.88
Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells. J Biol Chem (2005) 0.87
PvRON2, a new Plasmodium vivax rhoptry neck antigen. Malar J (2011) 0.87
Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes. Biochem Biophys Res Commun (2005) 0.87
Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates. Infect Genet Evol (2010) 0.87
Reference strand conformational analysis (RSCA) is a valuable tool in identifying MHC-DRB sequences in three species of Aotus monkeys. Immunogenetics (2006) 0.86
Identifying and characterising the Plasmodium falciparum RhopH3 Plasmodium vivax homologue. Biochem Biophys Res Commun (2007) 0.86
Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2. Biochem Biophys Res Commun (2005) 0.86
Cloning, expression, and characterisation of a Plasmodium vivax MSP7 family merozoite surface protein. Biochem Biophys Res Commun (2006) 0.85
Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions. Biochimie (2005) 0.85
The Plasmodium vivax rhoptry-associated protein 1. Biochem Biophys Res Commun (2006) 0.85
High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). Infect Genet Evol (2005) 0.85
Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. Vaccine (2004) 0.85
Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants. Clin Diagn Lab Immunol (2002) 0.85
Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics (2009) 0.84
MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochem Biophys Res Commun (2004) 0.84
The diagnostic performance of classical molecular tests used for detecting human papillomavirus. J Virol Methods (2012) 0.84
Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women. J Clin Microbiol (2013) 0.84
Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages. Immunogenetics (2006) 0.84
Identifying gp85-regions involved in Epstein-Barr virus binding to B-lymphocytes. Biochem Biophys Res Commun (2004) 0.84
Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34). Vaccine (2009) 0.84
Antigenic properties of the Leishmania infantum GRP94 and mapping of linear B-cell epitopes. Immunol Lett (2002) 0.84
Conserved high activity binding peptides are involved in adhesion of two detergent-resistant membrane-associated merozoite proteins to red blood cells during invasion. J Med Chem (2010) 0.84
Structure, Immunogenicity, and Protectivity Relationship for the 1585 Malarial Peptide and Its Substitution Analogues. Angew Chem Int Ed Engl (2001) 0.83
Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes. Protein Sci (2005) 0.83
Identification of the Plasmodium falciparum rhoptry neck protein 5 (PfRON5). Gene (2010) 0.83
Characterisation of the Plasmodium vivax Pv38 antigen. Biochem Biophys Res Commun (2008) 0.83
Identification and polymorphism of Plasmodium vivax RBP-1 peptides which bind specifically to reticulocytes. Peptides (2002) 0.83
Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells. Peptides (2005) 0.83
The Plasmodium vivax Pv41 surface protein: identification and characterization. Biochem Biophys Res Commun (2008) 0.83
Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC. Vaccine (2007) 0.83
Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue. Biochem Biophys Res Commun (2005) 0.83
Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen. BMC Microbiol (2010) 0.83
Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship. Malar J (2011) 0.83
Cutaneous tuberculosis diagnosis in an inhospitable Amazonian region by means of telemedicine and molecular biology. J Am Acad Dermatol (2005) 0.82
The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys. Vaccine (2007) 0.82
Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate. Eur J Pharm Sci (2011) 0.82
Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection. Vaccine (2009) 0.82
Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP). Vaccine (2003) 0.81
Allele effects in MHC-peptide interactions: a theoretical analysis of HLA-DRbeta1*0101-HA and HLA-DRbeta1*0401-HA complexes. Biochem Biophys Res Commun (2005) 0.81
NClassG+: A classifier for non-classically secreted Gram-positive bacterial proteins. BMC Bioinformatics (2011) 0.81
Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design. Clin Microbiol Rev (2006) 0.81
Protection against experimental malaria associated with AMA-1 peptide analogue structures. FEBS Lett (2002) 0.81
Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples. PLoS One (2013) 0.81
Limited genetic polymorphism of the Plasmodium vivax low molecular weight rhoptry protein complex in the Colombian population. Infect Genet Evol (2009) 0.81
Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides. Vaccine (2003) 0.81
A new approach to obtaining Nα -t-Boc-amino acid aldehydes from asparagine and glutamine for reduced amide pseudopeptide solid-phase synthesis. Chem Biol Drug Des (2011) 0.81
Differential expansion of the merozoite surface protein (msp)-7 gene family in Plasmodium species under a birth-and-death model of evolution. Mol Phylogenet Evol (2010) 0.81
Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes. Peptides (2003) 0.80
A theoretical analysis of HLA-DRbeta1*0301-CLIP complex using the first three multipolar moments of the electrostatic field. Biochimie (2006) 0.80
Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: a potential vaccine candidate. Vaccine (2009) 0.80